Antiangiogenic treatment with Sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats-Reference-Cited by-同舟云学术

Antiangiogenic treatment with Sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats

Published:2007-10-12 Issue:6 Volume:46 Page:1919-1926
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Tugues Sònia,Fernandez-Varo Guillermo,Muñoz-Luque Javier,Ros Josefa,Arroyo Vicente,Rodés Juan,Friedman Scott L.,Carmeliet Peter,Jiménez Wladimiro,Morales-Ruiz Manuel

Funder

Ministerio de Educación y Ciencia Plan Nacional de I+D+I

National Institutes of Health

Ministerio de Sanidad y Consumo

Publisher

Wiley

Subject

Hepatology

Reference30 articles.

1. Hepatic fibrosis as wound repair: a progress report;Bissell;J Gastroenterol,1998

2. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury;Friedman;J Biol Chem,2000

3. Angiogenesis in life, disease and medicine;Carmeliet;Nature,2005

4. Interleukin 6 induces the expression of vascular endothelial growth factor;Cohen;J Biol Chem,1996

5. The codependence of angiogenesis and chronic inflammation;Jackson;FASEB J,1997

Cited by 239 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HSP47 in human diseases: Navigating pathophysiology, diagnosis and therapy;Clinical and Translational Medicine;2024-08

2. Reduced risk of overt hepatic encephalopathy and death after transjugular intrahepatic portosystemic shunt in patients with hepatic venovenous communications;European Journal of Radiology;2024-08

3. The Therapeutic Effects of Baicalein on the Hepatopulmonary Syndrome in the Rat Model of Chronic Common Bile Duct Ligation;Journal of Clinical and Translational Hepatology;2024-03-18

4. Reversal of cholestatic liver disease by the inhibition of sphingosine 1-phosphate receptor 2 signaling;PeerJ;2024-01-16

5. Axitinib attenuates the progression of liver fibrosis by restoring mitochondrial function;International Immunopharmacology;2023-09